glp-1 class diabetes drugs What to Make of the Coverage and Cost Landscape GLP-1 Receptor Agonist Market Size
Description
With injections, you get the drug once a week
10.1111/dom.12352 8 BellG
[60] History and clinical trials [edit] In the 1970s, Jens Juul Holst and Joel Habener began research on GLP-1, initially in relation to duodenal ulcer disease
Figure 2 Exenatide, a peptide of 39 amino acids, has a much slower metabolism than endogenous GLP-1 (half-life of 3-4 h) (119, 120)
42 Warnings and precautions: Warnings and precautions for currently available SGLT-2 inhibitors are largely the same, with only a few small exceptions
